ArticleFrontiers in medicine2022

Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study.

Mohammad Shehab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.